Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187
- 8 September 2003
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (19) , 10629-10634
- https://doi.org/10.1073/pnas.1832879100
Abstract
Type IIA topoisomerases both manage the topological state of chromosomal DNA and are the targets of a variety of clinical agents. Bisdioxopiperazines are anticancer agents that associate with ATP-bound eukaryotic topoisomerase II (topo II) and convert the enzyme into an inactive, salt-stable clamp around DNA. To better understand both topo II and bisdioxopiperazine function, we determined the structures of the adenosine 5′-[β,γ-imino]-triphosphate-bound yeast topo II ATPase region (ScT2-ATPase) alone and complexed with the bisdioxopiperazine ICRF-187. The drug-free form of the protein is similar in overall fold to the equivalent region of bacterial gyrase but unexpectedly displays significant conformational differences. The ternary drug-bound complex reveals that ICRF-187 acts by an unusual mechanism of inhibition in which the drug does not compete for the ATP-binding pocket, but bridges and stabilizes a transient dimer interface between two ATPase protomers. Our data explain why bisdioxopiperazines target ATP-bound topo II, provide a structural rationale for the effects of certain drug-resistance mutations, and point to regions of bisdioxopiperazines that might be modified to improve or alter drug specificity.Keywords
This publication has 62 references indexed in Scilit:
- The ATP-operated Clamp of Human DNA Topoisomerase IIα: Hyperstimulation of ATPase by “Piggy-back” BindingJournal of Molecular Biology, 2002
- Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF‐187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase IIαFEBS Letters, 2002
- An Open Conformation of the Thermus thermophilusGyrase B ATP-binding DomainJournal of Biological Chemistry, 2002
- Anthracycline-induced cardiomyopathySeminars in Oncology, 2001
- Use of TLS parameters to model anisotropic displacements in macromolecular refinementActa Crystallographica Section D-Biological Crystallography, 2001
- N-terminal and core-domain random mutations in human topoisomerase II α conferring bisdioxopiperazine resistanceFEBS Letters, 2000
- [20] Processing of X-ray diffraction data collected in oscillation modePublished by Elsevier ,1997
- Nucleotide Binding to the 43-Kilodalton N-Terminal Fragment of the DNA Gyrase B ProteinBiochemistry, 1995
- Crystallization of Inhibitor Complexes of an N-Terminal 24 kDa Fragment of the DNA Gyrase B ProteinJournal of Molecular Biology, 1994
- The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugsBiochemistry, 1993